retatrutide peptide function The power of three: Retatrutide's role in modern obesity and diabetes therapy Retatrutide UK 2026: Phase 3

Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): A double-blind, phase 3b, randomised controlled trial

While uncommon, these serious adverse events require ongoing monitoring and risk assessment, particularly with long-term therapy

FDA Not in the pill form right now but letss go with it

Does triple agonism produce better outcomes than dual or single agonism

Phase II studies revealed mean weight losses of 17.5% at 24 weeks and 24.4% at 48 weeks

Hypothalamus & Pituitary: GLP-1 enhances GnRH release via kisspeptin/GABA neurons, leading to increased LH and FSH secretion